IP Library Granted Patent US 10,197,574
Granted Patent B2
US 10,197,574 · App. 15/009,213 · Granted Feb 5, 2019

Analyte detection using near-infrared fluorophores

Inventors: Robert Michael Strongin (Portland, OR); Martha Sibrian-Vazquez (Portland, OR); Jorge Omar Escobedo-Cordova (Portland, OR); Mark Allen Lowry (Portland, OR)
Assignee: Portland State University
G01N33/582C07D405/14C09B11/24C09K9/02C09K11/06G01N33/52G01N33/6815C09K2211/1007C09K2211/1029C09K2211/1088G01N2800/28Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,197,574
App. No.
15/009,213
Granted
Feb 5, 2019
Kind
B2
Abstract

Embodiments of compounds for selectively detecting an analyte are disclosed, along with methods and kits for detecting analytes with the compounds. The compounds are bridged viologen conjugates including at least one fluorophore according to the general structure At least one of R 1 /R 2 , R 2 /R 3 , R 3 /R 4 , R 5 /R 6 , R 6 /R 7 , and/or R 7 /R 8 together form a substituted or unsubstituted cycloalkyl or aryl.

Claims (28)

1. A compound according to Formula III

where X − is a halide or PF 6 − , and

each of R A and R B independently is a fluorophore having a structure according to formula (iii)

where each bond depicted as “ ” is a single or double bond as needed to satisfy valence requirements;

X 1 is O;

R 1 and R 2 independently are hydrogen, hydroxyl, oxygen, thiol, lower alkyl, carboxyalkyl, amino, alkoxy, halogen, or —NHR c where R c is

R 5 , R 7 , and R 8 independently are hydrogen, hydroxyl, thiol, lower alkyl, carboxyalkyl, amino, alkoxy, or halogen;

is hydrogen, hydroxyl, halogen, oxygen, sulfur, thiol, amino, alkyl amino, imino, iminium, alkyl imino, alkyl iminium, cycloalkyl imino or —NHR c ;

R 9 -R 12 independently are hydrogen, alkyl, carboxyl, nitro, amino, alkyl amino, or —SO 3 H;

R 13 is hydrogen, hydroxyl, lower alkyl, lower alkoxy, —SO 3 H or —COOR 14 where R 14 is hydrogen or lower alkyl and the bond depicted as “ ” in ring B is a double bond, or R 13 is one or more atoms forming a ring system with rings B and D and the bond depicted as “ ” in ring B is a single bond; and

at least one of R 1 , R 2 , or -R 5 -R 18 is a linker covalently binding the fluorophore to the viologen backbone,

wherein at least one of R 1 and R 8 is other than hydrogen, or R 13 is hydrogen, lower alkyl, lower alkoxy, or —SO 3 H, or R 13 is one or more atoms forming a ring system with rings B and D and the bond depicted as “ ” in ring B is a single bond, or R 5 is the linker.

2. The compound of claim 1 where R 13 is the linker.

3. The compound of claim 1 where R 13 is —COO— and forms a lactone ring, and at least one of R 1 , R 2 , or R 5 -R 12 or -R 15 -R 18 is the linker.

4. The compound of claim 1 where the fluorophore has a structure according to:

(a) formula (iii) R 18 is halogen, hydroxyl, thiol, amino, alkyl amino, or alkoxy; or

(b) formula (iii) where R 6 and R 16 are —NHR c .

5. A method for detecting an analyte, comprising:

forming a solution by combining a sample comprising an analyte with a compound according to claim 1 ;

allowing a reaction between the analyte and the compound in the solution to proceed for an effective period of time to a produce a detectable change in the solution's absorbance spectrum, emission spectrum, or both, where the change indicates that the analyte is present; and

detecting the change.

6. The method of claim 5 where detecting the change comprises:

exposing the solution to a light source; and

detecting the analyte by detecting fluorescence from the compound at a wavelength corresponding to an emission spectrum maximum of the compound after the reaction has proceeded for the effective period of time.

7. The method of claim 5 where the analyte comprises cysteine, homocysteine, glutathione, succinyl-5-amino-4-imidazolecarboxamide riboside, succinyladenosine, or a combination of succinyl-5-amino-4-imidazolecarboxamide riboside and succinyladenosine.

8. The method of claim 7 where the analyte is succinyl-5-amino-4-imidazolecarboxamide riboside, succinyladenosine, or a combination thereof, and the compound comprises at least one fluorophore according to:

(a) formula (iii):

where X 1 is oxygen and R 6 and R 16 are —NHR c .

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 30, 2019
From: PORTLAND STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048196/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2016
From: STRONGIN, ROBERT MICHAEL; SIBRIAN-VAZQUEZ, MARTHA; ESCOBEDO-CORDOVA, JORGE OMAR; LOWRY, MARK ALLEN
To: THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY
Reel/Frame 037669/0836 →
ENTITY CONVERSION Recorded Feb 4, 2016
From: THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY
To: PORTLAND STATE UNIVERSITY
Reel/Frame 037701/0120 →
Continuity (4)
Continuation 14129234
Provisional Application 61505029 · Jul 6, 2011
Provisional Application 61502795 · Jun 29, 2011
Related Publication 20160223558A1 · Aug 4, 2016